600211 Tibet Rhodiola Pharmaceutical Holding
- 38.31
- -0.63-1.62%
About Tibet Rhodiola Pharmaceutical Holding Company
The company was founded in the Tibet Autonomous Region on July 14, 1999, and traded online on the Shanghai Stock Exchange on July 21, 1999. It is the first high-tech pharmaceutical listed company in the Tibet Autonomous Region. The company's industry is pharmaceutical manufacturing. It mainly produces and sells capsules, biologics, granules, coating agents, etc. The company's main products cover cardiovascular, hepatobiliary, sprain, rheumatism, rheumatism, rheumatoid, colds, etc. Representative varieties include Neoactive, Imdo, Nordicom, Shiweidida capsules, Xueshan Jinluohan pain relief coating, and Shuangqing granules for children. Corporate honors: National High-tech Enterprise, National Certified Enterprise Technology Center, National Key Leading Enterprise in Agricultural Industrialization, Jinniu's Most Investment Value Award, Biomedical Most Growing Listed Company, China's Top 100 Chinese Medicine Industry Enterprises, Tibet Autonomous Region Specialized and New Small and Medium Enterprises, Tibet Autonomous Region Top 20 Private Enterprises, Top 100 Main Board Listed Companies, 2023 Board Secretary Performance Evaluation 4A Rating, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- dabin chen
- Chairman, Directors, Chairman of the Strategy Committee
- 3.44M
- yucheng zhou
- Vice Chairman, Directors, Audit Committee Members
- 1.81M
- sanyan wu
- Directors, Strategy Committee Members
- 80.00K
- yufang li
- Directors, Member of the Remuneration and Assessment Committee
- 80.00K
- yuandong guo
- Directors, General Manager, Strategy Committee Members
- 3.44M
- lieyi ma
- Directors, Strategy Committee Members
- 80.00K
- yu zhang
- Independent Directors, Audit Committee Members, Chairman of the Remuneration and Assessment Committee
- 180.00K
- jiankun lin
- Independent Directors, Member of the Remuneration and Assessment Committee
- 120.00K
- jiayun man
- Independent Directors, Chairman of the Audit Committee, Strategy Committee Members
- 180.00K
- lan liu
- Board Secretary, Deputy General Manager
- 1.07M
- lili wen
- Securities Affairs Representative
- --
- pei yao
- Chairman of the Supervisory Board, Employee Supervisors
- 530.40K
- tiantian tang
- Auditors
- 197.00K
- ting zhang
- Auditors
- 50.00K
- bo tang
- Deputy General Manager
- 905.30K
- yongguo yuan
- Deputy General Manager
- 1.06M
- jun chen
- Chief Financial Officer
- 736.70K
- dongsheng ren
- Director of the Technology Center
- --
Analysis
Price Target
No Data
No Data